Learning Objectives

Learning Objectives

1. Discuss appropriate use of enteral (per GI tract) and parenteral (IV) nutrition in a variety of patient settings and clinical conditions.
2. Recognize the criteria used to define malnutrition.
3. Describe the impact of dose and timing of enteral nutrition on clinical outcomes.
4. Compare and contrast 2:1 and 3:1 parenteral nutrition solutions.
5. Explain the impact of stability and compatibility in parenteral nutrition solutions.


Author

Kelly Kinnare, MS, RD, LDN, CNSC
Director, Clinical Nutrution
American Society for Parenteral and Enteral Nutrition
Silver Spring, MD


This module will provide 2.5 contact hours (0.25 CEUs) of continuing pharmacy education credit for pharmacy technicians.

ACPE UAN: 0121-0000-24-004-H01-T
Activity type: Knowledge-based

Release date: October 1, 2024
Expiration date: September 30, 2027

2.5 HOURS CE    ACPE UAN: 0121-0000-24-004-H01-T    RELEASED: 10/1/2024    EXPIRES: 9/30/2027

Kelly Kinnare, MS, RD, LDN, CNSC
Director; Clinical Nutrition; Bannockburn, IL

Kelly Kinnare is the Director of Development and Strategic Partnerships for the American Society for Parenteral and Enteral Nutrition (ASPEN). Kelly has been a Registered Dietitian for over 19 years. She received her Bachelor’s degree in Dietetics at Western Michigan University and then went on to complete her Master’s degree/Dietetic internship at Rush University in Chicago, IL. Kelly has spent her entire career in the field of nutrition support – first as a Nutrition Support Dietitian at Rush University Medical Center in Chicago, IL, and then as the Director of Clinical Nutrition for Option Care Health. She has been actively involved in research with over 15 publications in the area of nutrition support, including peer-reviewed manuscripts, review articles, book chapters, and abstracts.